[Retracted] mRNA-Modified FUS/NRF2 Signalling Inhibits Ferroptosis and Promotes Prostate Cancer Growth

Figure 7

Effects of Erastin, ferroptosis rroptosis death inhibitors, and FUS knockdown on GSH and ROS. (a) GSH expression in LNCaP cells after treatment. (b) GSH expression in C42 cells after treatment. (c) ROS expression in LNCaP cells after treatment. (d) ROS expression in C42 cells after treatment.

(a)

(b)

(c)

(d)